COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...
In the U.S., Moderna withdrew its approval application for the combination vaccine in May last year and the timeline for ...
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...
Older adults across the European Union are a step closer to replacing two annual jabs with one. In late February 2026, the ...
A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now ...
The European Commission granted marketing authorization for mCombriax in individuals 50 years of age and older, covering all 27 EU member states, as well as Iceland, Liechtenstein and Norway. The ...
The American pharmaceutical and biotechnology company Moderna has initiated a large clinical trial around a vaccine designed ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's fourth authorized productmCOMBRIAX will be made available in the European Union, subje ...
Moderna Inc. MRNA shares are up on Tuesday as the company received marketing authorization for its mCOMBRIAX vaccine, the ...
Sheila Cherfilus-McCormick (D-Fla.) resigned from Congress; she and her brother are alleged to have stolen $5 million from ...